Radiopharmaceuticals for PET Imaging - Issue A

• Beste egile batzuk: Roivainen, Anne (Argitaratzailea), Li, Xiang-Guo (Argitaratzailea)
• Formatua: Baliabide elektronikoa Liburu kapitulua
• Hizkuntza: ingelesa
• Argitaratua: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
• Gaiak: Medicine; kinetic analysis; Siglec-9; gallium-68; vascular adhesion protein; VAP-1; infection; inflammation; osteomyelitis; animal model; Staphylococcus aureus; multiple myeloma; positron emission tomography/computed tomography; radiopharmaceuticals; 18F-fluorodeoxyglucose; tetrazine ligation; PET; SPECT; indium-11; fluorine-18; positron emission tomography (PET), defluorination; isotopic exchange; silicon-based fluoride acceptor; bioorthogonal chemistry; tetrazine; inverse electron-demand Diels-Alder ligation; opioid; naloxone; overdose; fentanyl; carfentanil; [11C]carfentanil; positron emission tomography; receptor occupancy; pharmacokinetics; [18F]AlF; NOTA; NODAGA; PODS; thiol-reactive; linker; affibody molecule; bioconjugation; EGFR; tumor imaging; vulnerable plaque; molecular imaging; PET imaging; nanobody; single-domain antibody; sub-millimetre resolution; AlF-radiolabelling; preclinical radiopharmaceutical dosimetry; image-based internal dosimetry; OLINDA; MCT1/MCT4 lactate transporter inhibitor; [18F]FACH; radiation safety; sigma-1 receptor availability; orthotopic xenograft of glioblastoma in mouse; small animal Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI); (S)-(−)-[18F]fluspidine; imaging-based biomarker; SV2A protein; PET radiotracers; synaptic loss; radiochemistry; preclinical development; clinical outcomes; monocarboxylate transporters (MCTs); FACH; 18F-labeled analog of FACH; α-CCA; blood-brain barrier (BBB); positron emission tomography (PET) imaging; peptides; proteolysis; metabolic stability
• Sarrera elektronikoa: DOAB: download the publication; DOAB: description of the publication

Positron emission tomography (PET) is a very useful technique for medical diagnosis and drug development. Radiopharmaceuticals are a key element in PET techniques and one of the pivotal factors influencing the applications of PET. The aim of this Special Issue of Molecules is to report on the recent...